ISOLATED NUCLEIC ACID MOLECULE WHICH ENCODES MURINE TUMOR REJECTION ANTIGEN PRECURSOR SMAGE-3 - Patent 0873350

(19)

(11)

EP 0 873 350 A1

(12)

(43)	Date of publication:
	28.10.1998 Bulletin 1998/44

(21)	Application number: 96921675.0

(22)	Date of filing: 18.06.1996

(51)

International Patent Classification (IPC):

C12N 15/ 09^{( . )}
C07K 14/ 47^{( . )}
C12N 1/ 21^{( . )}
C12Q 1/ 68^{( . )}

A61K 39/ 00^{( . )}
C12N 1/ 11^{( . )}
C12N 5/ 10^{( . )}

(86)	International application number:
	PCT/US1996/010518

(87)	International publication number:
	WO 1997/001574 (16.01.1997 Gazette 1997/04)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

29.06.1995 US 19950496517

(71)	Applicant: LUDWIG INSTITUTE FOR CANCER RESEARCH
	New York, New York 10105 (US)

(72)	Inventors:
	DeBACKER, Olivier B-1200 Brussels (BE) DePLAEN, Etienne B-1200 Brussels (BE) BOON-FALLEUR, Thierry B-1200 Brussels (BE)

(74)	Representative: Fyles, Julie Marie, et al
	Markgraaf Patents Limited The Crescent 54 Blossom Street York YO24 1AP York YO24 1AP (GB)

(54)	ISOLATED NUCLEIC ACID MOLECULE WHICH ENCODES MURINE TUMOR REJECTION ANTIGEN PRECURSOR SMAGE-3